Viewing Study NCT02000102


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2025-12-26 @ 2:29 AM
Study NCT ID: NCT02000102
Status: COMPLETED
Last Update Posted: 2014-11-18
First Post: 2013-11-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab
Sponsor: Stanford University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module